Smartleaf Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Smartleaf Asset Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68.2K	Hold	231	–	–	﹤0.01%	1361
2026 Q1	$62.5K	Buy	231 +196	+560%	+$56.4K	﹤0.01%	1337
2025 Q4	$10.7K	Sell	35 -43	-55%	-$13.4K	﹤0.01%	2370
2025 Q3	$21.1K	Buy	78 +69	+767%	+$18.8K	﹤0.01%	1797
2025 Q2	$2.19K	Sell	9 -10	-53%	-$2.36K	﹤0.01%	2311
2025 Q1	$4.62K	Sell	19 -57	-75%	-$17.1K	﹤0.01%	2213
2024 Q4	$24.8K	Sell	76 -4	-5%	-$1.36K	﹤0.01%	1526
2024 Q3	$26.5K	Buy	80 +40	+100%	+$12.7K	﹤0.01%	1186
2024 Q2	$10.9K	Buy	40 +2	+5%	+$582	﹤0.01%	1367
2024 Q1	$13.3K	Buy	+38	New	+$12.5K	﹤0.01%	935

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Smartleaf Asset Management's BIO Position: Q2 2026 in Review

Smartleaf Asset Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 231 shares worth $68.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1361.

Smartleaf Asset Management first reported a position in BIO in Q1 2024 and has held it in 10 quarters since. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Smartleaf Asset Management held 231 shares of Bio-Rad Laboratories Class A worth $68.2K as of Q2 2026.
Smartleaf Asset Management left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1361 holding.
Smartleaf Asset Management first reported a position in Bio-Rad Laboratories Class A in Q1 2024 and has held it in 10 quarters since.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.